Clinical trial

Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors

NCT02207348

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-08-01

PhasePHASE1

Study timeline

Study start (unknown)2014-08-01Date precision: month

Registry last updated2016-12-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metabolism and Nutrition Disorderunresolved

Obesityunresolved

Interventions

liraglutideDRUG · verified · RxNorm: liraglutide

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02207348 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.